IONS Competitors & Alternatives
Compare Ionis Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
IONS
Main Stock$75.54
Tradestie Score
63
Market Cap
$10.49B
Revenue Growth
0.9%
Analyst Upside
+33.4%
Top Competitors
227 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
RPRX
Royalty Pharma plc Class A Ordinary Shares
|
$52.99
|
$15.70B | 27.2 | 67 | Compare |
|
SMMT
Summit Therapeutics Inc. Common Stock
|
$18.05
|
$15.22B | - | 49 | Compare |
|
ASND
Ascendis Pharma A/S American Depositary Shares
|
$242.75
|
$12.36B | 26.7 | 59 | Compare |
|
EXEL
Exelixis Inc
|
$51.17
|
$11.09B | 16.4 | 61 | Compare |
|
ROIV
Roivant Sciences Ltd. Common Shares
|
$29.32
|
$10.76B | - | 68 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$50.60
|
$10.74B | - | 57 | Compare |
|
BMRN
BioMarin Pharmaceuticals Inc
|
$53.25
|
$10.53B | 37.8 | 60 | Compare |
|
BBIO
BridgeBio Pharma, Inc. Common Stock
|
$69.33
|
$10.22B | - | 55 | Compare |
|
MDGL
Madrigal Pharmaceuticals, Inc. Common Stock
|
$540.79
|
$10.01B | - | 57 | Compare |
|
TECH
Bio-Techne Corp.
|
$45.10
|
$9.33B | 67.7 | 47 | Compare |
More IONS Analysis
Data updated: May 14, 2026 | Industry: Biotechnology (SIC 2834)
227 stocks in this industry